Amyris (AMRS) Complete $42.3M Private Placement, Starts Biofene Production

December 27, 2012 8:03 AM EST Send to a Friend
Amyris, Inc. (Nasdaq: AMRS) has completed a $42.25 million private placement of its common stock. In addition, Amyris announced its purpose-built industrial fermentation facility in Brazil has successfully begun production of Biofene, Amyris's brand of renewable farnesene.

"We are encouraged by the continued, strong commitment from our major investors, particularly as we start up our new industrial fermentation facility for the production of our renewable hydrocarbons in Brazil," said John Melo, Amyris President & CEO.

"Our own farnesene plant at Paraiso has been successfully commissioned, with initial farnesene production underway. We anticipate sales from this facility during the first quarter of 2013," Melo concluded.

The Company sold 14,177,849 shares of common stock in a private placement to existing Amyris investors. The transaction included $37.25 million in cash proceeds and the conversion by Total Gas & Power USA, SAS of $5 million from an outstanding senior unsecured convertible promissory note. Additional details will be provided in the Company's upcoming SEC filings.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, Equity Offerings, FDA

Add Your Comment